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INTRODUCTION 
Pulmonary Hypertension (PH) can be 
found in 9 to 35% of patients with atrial septal 
defect (ASD). It is a consequence of increased 
left to right shunt resulting in volume overload of 
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ABSTRACT
Pulmonary hypertension is a common complication of congenital heart disease due to 
systemic – pulmonary circulation shunt which if left uncorrected leads to increased pulmonary 
artery pressure, vascular remodeling and further increase of pulmonary vascular resistance. 
Percutaneous closure of the defect interrupts this shunt thus reducing right heart and 
pulmonary circulation load and pulmonary artery pressure. In this paper we present two cases 
of percutaneous secundum atrial septal defect closure complicated by pulmonary hypertension 
along with echocardiographic evaluation of cardiopulmonary hemodynamic changes before 
and shortly after device closure. Forty years old and thirty three years old females presented 
to our clinics with classical symptoms of atrial septal defects, assessment revealed TVG of 
37 mmHg and 30 mmHg,shortly after the procedure patient was re-evaluated and revealed 
TVG of 39 mmHg and 23 mmHg respectively. From these cases we conclude that changes in 
pulmonary artery pressure is not constantly found after device closure. However both patients 
display improvements in functional capabilities.
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INTISARI
Hipertensi pulmonal adalah komplikasi umum pada kelainan jantung kongenital yang diakibatkan 
oleh shunt sirkulasi sistemik-pulmonal yang jika dibiarkan tidak dikoreksi akan menyebabkan 
peningkatan tekanan arteri pulmonal, perubahan vaskular dan peningkatan resistensi pembuluh 
darah pulmonal. Penutupan defek menghentikan aliran melalui shunt sehingga mengurangi beban 
sirkulasi jantung kanan dan tekanan arteri pulmonal. Dalam makalah ini kami mempresentasikan 
dua kasus penutupan defek septum atrium dengan hipertensi pulmonal disertai evaluasi 
ekokardiografi terhadap perubahan hemodinamika kardiopulmonal sebelum dan sesaat setelah 
penutupan defek. Perempuan berusia 40 dan 34 tahun berkunjung ke klinik kami dengan gejala 
klasik defek septum atrium, pemeriksaan menunjukan TVG 37 mmHg dan 30 mmHg. Setelah 
penutupan defek, re-evaluasi menunjukan TVG 39 mmHg dan 23 mmHg. Dari kasus ini kita 
dapat menyimpulkan bahwa perubahan tekanan arteri pulmonal setelah penutupan defek tidak 
selalu didapati, namun demikian kedua pasien menunjukan perbaikan klinis.
the right heart and pulmonary circulation.1 If left 
untreated pulmonary hypertension might further 
develop into right heart failure, arrhythmia, and 
thromboembolic events.2 Percutaneous closure 
has become a preferred treatment in patients 
107  
Acta Cardiologia Indonesiana (Vol 3 No. 2): 106-112
and IVC collapse of less than 50%, right atrial 
and ventricular dilatation, no left ventricle (LV) 
D-shaped. Tricuspid valve pressure gradient 
(TVG) was 37 mmHg with estimated mean 
pulmonary arterial pressure (mPAP) of 37 mmHg 
and estimated right systolic ventricular pressure 
of 57 mmHg. Tricuspid regurgitation (TR) Vmax 
was 3.03 m/s with PV Acceleration Time of 94 ms. 
There was no anomalous pulmonary connection. 
Right heart catheterization confirms the presence 
of pulmonary hypertension with PA pressure 
26/24 mmHg. Three months later evaluation with 
transesophageal echocardiography (TEE) was 
done, there was 1.6-2.3 cm secundum ASD with 
left to right shunts and pulmonary hypertension 
with TVG 35mmHg. Rim assessment proved 
suitable for device closure. She underwent 
device closure procedure with amplatzer 
with secundum type ASD. It does not only 
increases exercise tolerance, it also improves 
heart hemodynamics.3 These cases evaluate 
the hemodynamic effects of percutaneous 
atrial septal defects closure on pulmonary 
hypertension.
CASE PRESENTATION
Case 1
Forty years old female came to our clinics 
with complaint of chest pain, palpitations 
and dyspnea on effort since last 1 year. On 
examinations, she had wide fixed splitting heard 
best at 3rd ICS. Chest X-ray showed cardiomegaly 
and peripheral pruning. Electrocardiogram (ECG) 
showed sinus rhythm with incomplete right bundle 
branch block. Transthoracic echocardiography 
(TTE) revealed inferior vena cava (IVC) dilatation 
Figure 1. Case 1 Pre ASO evaluation. A. Atrial Septal Defect. B. Transvalvular Gradient
Figure 2. Case 1 Post ASO evaluation. A. Atrial Septal Defect. B. Transvalvular Gradient
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septal occluder (ASO). After the procedure, 
heart hemodynamics was re-evaluated with 
transthoracic echocardiography. Estimated 
mPAP was 36 mmHg, TVG was 39 mmHg, TR 
Vmax 3.13 m/s, and PV Acceleration Time 88 ms. 
On follow up, patient feel better with increased 
functional class.
Case 2
A thirty four years old female came to our 
clinics with a complaint of palpitation since 1 
year ago and recurrent dyspnea for the past 
three months and exercise intolerance. On 
examinations, she had wide fixed splitting with 
ECG showing incomplete right bundle branch 
block. There was no history of paradoxical 
embolism. TEE was performed confirming 
diagnosis of secundum Atrial Septal Defects with 
left to right shunts and an estimated diameter 
of 1.6-2.3cm. TVG was 30 mmHg. As rim was 
suitable for ASD closure, she was then planned 
to undergo TEE guided ASD closure. After 
closure, assessment showed good placement 
of septal occluder device, with TVG 23 mmHg 
and there was no IVC dilatation, IVC collapse 
was less than 50%. On follow up there was no 
complication. On follow up patient no longer 
experience dyspnea and there was no other 
complaint.
DISCUSSION
Pulmonary hypertension is a progressive 
disease characterized by increased of mPAP 
of >25 at rest and an elevation of pulmonary 
vascular resistance (PVR) of more than 3 Woods 
Unit (WU) with normal PA wedge pressure of 
<15 mmHg.4 Definitive diagnosis is to be made 
by right heart catheterization (RHC). Although it 
is a relatively safe procedure, RHC is invasive 
and thus a noninvasive alternative is desirable 
for early diagnosis of PH. Echocardiography 
Figure 4. Case 2 Post ASO evaluation. A. Atrial Septal Defect. B. Transvalvular Gradient
Figure 3. Case 2 Pre ASO evaluation. A. Atrial Septal Defect. B. Transvalvular Gradient
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has been used to estimate presence of PH 
and to assess morphological and functional 
consequences of PH.It can be used to assess 
several variables that had significant prognostic 
values and plays a role in monitoring patient’s 
response to therapy.5
PH associated with congenital heart 
disease (CHD) is classified in Pulmonary Arterial 
Hypertension (PAH) - Group I according to ESC 
guideline along with idiopathic PH, familial PH, 
drugs and toxin induced PH, PH associated with 
connective tissue disease, HIV infection, portal 
hypertension and schistosomiasis.6Five to ten 
percent of patients with PAH have congenital 
heart disease, and one of the most common 
CHD is atrial septal defects.4
Atrial septal defect maybe single or 
multiple and can be located anywhere along the 
atrial septum. Embryologically, atrial septation 
involves septum primum, septum secundum 
and atrioventricular (AV) canal septum. Normal 
development of the atrial septum results in the 
formation of fossa ovalis bounded by septum 
secundum. Secundum atrial defect is the most 
common congenital heart defect that causes 
systemic - pulmonary circulation shunting 
and is frequently due to deficiency of septum 
primum.7Patients with isolated ASD are usually 
asymptomatic during the first two decades of 
life. As patients reaches adulthood, around 
the fourth decades of life,the degree of left to 
right shunt increases as ventricular compliance 
decreases accompanied by increase in systemic 
vascular resistance. These changes lead to 
several clinical manifestations such as exercise 
intolerance and palpitation that frequently occur 
as a result of right heart chamber enlargement, 
pulmonary hypertension, RV failure, tricuspid 
regurgitation and atrial arrhythmias. Which if 
left untreated will progress into right sided heart 
failure. Life expectancy is not normal in patients 
with untreated ASD, mortality increases by 6% 
per year after forty years old.8
With increased left to right shunt, there is 
increased flow to the right heart and pulmonary 
circulation, and thus increased pulmonary 
artery flow. At this point, correction of pulmonary 
artery hypertension is still reversible. However, 
prolonged exposure to increased flow to the 
pulmonary artery leads to remodeling of the 
pulmonary vasculature. Intimal fibrosis and 
hypertrophy of medial smooth muscle layer of 
pulmonary artery cause narrowing of lumen. 
These changes increases PVR and thus 
increased pulmonary artery pressure. This 
creates pressure overload in the right ventricle. 
Pressure overload increases the work of 
ventricle leading to right ventricular and right 
atrial dilatation, which further progress to 
right ventricular dysfunction, abnormal inter-
ventricular septal motion and dilatation of the 
superior and inferior vena cava and hepatic 
veins, as well as pericardial effusion.5,9,10 
With progressive increase of the right heart 
pressure and pulmonary vascular resistance, 
eventually reversal of shunt may arise,developing 
Eisenmenger syndrome. Eisenmenger syndrome 
is the most advanced form of PAH-CHD which 
was defined in 1958 as pulmonary hypertension 
at systemic level due to high pulmonary vascular 
resistance with reversed or bidirectional flow 
through a septal defect. With reversal of shunt 
directions, symptoms arise from hypoxemia. 
Reduced hemoglobin saturation stimulates 
bone marrow production of red blood cells 
(erythrocytosis). This can cause hyperviscosity 
manifesting as fatigue, headache, and stroke 
due to cerebrovascular occlusion. Hemoptysis 
may occur in case of pulmonary artery infarct/
rupture.11,12 When Eisenmenger syndrome 
developed, there is no remedies to turn back 
the disease process, although some treatment 
strategies can be applied, the only effective 
long-term strategy for severely affected patients 
is lung / heart-lung transplantation.12 However 
this is limited to the scarcity of donor organs and 
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lack of organ specificity in developing countries.11 
Fortunately, with early detection and correction of 
congenital heart defects, Eisenmenger syndrome 
has become less common.12
Small defects often close spontaneously 
within the first few years of life. However, 
significant ASD (Qp/Qs of > 1.5) seldom do, 
therefore they are closed surgically or by 
interventional catheter techniques before 
school age or at the time of diagnosis later in 
life.13Closure of interatrial septal defects closes 
the left to right shunt, resulting in reduction 
of volume overload on the right heart and 
pulmonary circulation. Thus pulmonary vascular 
disease might be prevented or reversed with 
early correction of the defects.1Surgical closure 
of the defects has been practiced for over 
45 years, but over the past three decades 
transcatheter device closure has evolved and is 
increasingly used in recent years. A wide variety 
of device has been developed for transcatheter 
closure of ASD, in this study we demonstrate the 
use of Amplatzer septal occluder (ASO) device. 
ASO is one of the commonly used device, safe, 
easy to use and has high success rate(98.4%). 
On comparison, success rate for both surgical 
or transcatheter device closure is not statistically 
different. However, complication rate was 
lower and length of stay was shorter in device 
closure patients.14 It is also easily visualized 
on TEE and fluoroscopy. In the last decade it 
has become the treatment of choice for device 
closure. Successful closure is complete closure 
with residual shunts of less than 1-2 mm, while 
long-term success is associated with reduced 
RV pressure and PH.Possible complications 
include gastroinstestinal or intracranial bleeding 
due to use of antiplatelet/ anticoagulant, device 
embolization, atrial arrhythmia (2-4%), catheter 
related thrombus formation, air embolism, 
pericardial effusion, and transient ischemic 
attack or stroke.15
In this paper we evaluate changes in 
pulmonary hypertension after device closure by 
echocardiography. Estimation of PA pressure by 
echocardiography can be made by assessing 
estimating tricuspid valve pressure gradient. 
Aside from that, RA pressure estimation can 
be used to evaluate right heart hemodynamics. 
Estimation of RA pressure can be made with IVC 
diameter and degree of inspiratory collapse.1,16,17 
The first case displayed no changes in TVG 
while having increased clinical performance. This 
could be caused by a long standing pulmonary 
hypertension leading to pulmonary vascular 
remodeling causing increased pulmonary 
vascular resistance and reduced compliance.18 
Or because of the reduced compliance of the 
left ventricle in comparison to right ventricular 
compliance.19Meanwhile, the second case 
displayed changes in TVG after device closure 
and clinical improvements. This difference in 
TVG evaluation result might be caused by a 
ten year age difference. Studies have shown 
that aging correlates with increased pulmonary 
systolic arterial pressure.20In older patients, 
ASD closure resulted in further deterioration 
of LV relaxation impairment and increased LV 
stiffness.21 Despite the difference in PH changes 
after percutaneous ASD closure, both patients 
display clinical improvements.
CONCLUSION
From the cases above, acute hemodynamic 
changes of the pulmonary artery is not constantly 
found subsequent to percutaneous closure of 
atrial septal defect. Even so, without significant 
changes of pulmonary artery pressure, our 
patients had improved functional capabilities. 
However due to limitations regarding the small 
sample size, this conclusion is prematurely 
made, thus further study is required. 
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